Advertisement

Current Psychiatry Reports

, Volume 6, Issue 6, pp 430–437 | Cite as

Increased mortality in depressive disorders: A review

  • Pim Cuijpers
  • Robert A. Schoevers
Article

Abstract

Several factors have been proposed to explain the relationship between excess mortality and depressive disorders. These include mechanisms such as increased suicide rates, hazardous health behavior (smoking, alcohol use, unhealthy eating), psychologic reactions to developing a medical illness, biological dysregulations (hyperactivity of the hypothalamic pituitary adrenal, neuro-immune dysregulation, sympathoadrenergic dysregulation), and noncompliance with medical treatment. The evidence supporting the role of each of these mechanisms in excess mortality varies considerably. The causal direction in most of the mechanisms is not clear. It is possible that the explanatory factors, such as smoking, compliance, or biological mechanisms, cause depression, or that depression causes these factors, or that both are explained by a third, underlying factor. We will summarize the evidence supporting these mechanisms, and propose options for possible interventions aimed at reducing the increased risk of dying.

Keywords

Depressive Disorder Major Depression Excess Mortality Hypothalamic Pituitary Adrenal Axis Consult Clin Psychol 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References and Recommended Reading

  1. 1.
    Brown S: Excess mortality in schizophrenia; a meta-analysis. Br J Psychiatry 1997, 171:502–508.PubMedGoogle Scholar
  2. 2.
    Pokorski RJ: Underwriting psychiatric impairments, with emphasis on depression; part I: psychiatric mortality and common underwriting parameters. J Insurance Med 1994, 26:46–56.Google Scholar
  3. 3.
    Harris EC, Barraclough B: Excess mortality of mental disorder. Br J Psychiat 1998, 173:11–53. This is a systematic review of studies examining the relationship between excess mortality and most mental disorders, including major depression and other mood disorders.Google Scholar
  4. 4.
    Cuijpers P, Smit F: Excess mortality in depression: a meta-analysis of community studies. J Affect Disord 2002, 72:227–236. This is a quantitative meta-analysis of prospective community studies examining the mortality of subjects with depression.PubMedCrossRefGoogle Scholar
  5. 5.
    Januzzi Jr JL, Stern TA, Pasternak RC, DeSanctis RW: The influence of anxiety and depression on outcomes of patients with coronary artery disease. Arch Intern Med 2000, 160:1913–1921.PubMedCrossRefGoogle Scholar
  6. 6.
    Frasure-Smith N, Lesperance F, Talajic M: Depression following myocardial infarction. Impact on 6-month survival. JAMA 1993, 270:1819–1825.PubMedCrossRefGoogle Scholar
  7. 7.
    Frasure-Smith N, Lesperance F, Talajic M: Depression and 18-month prognosis after myocardial infarction. Circulation 1995, 15:999–1005.Google Scholar
  8. 8.
    Aromaa A, Raitasalo R, Reunanen A, et al.: 1994. Depression and cardiovascular diseases. Acta Psychiatr Scand 1994, 377(suppl):77–82.Google Scholar
  9. 9.
    Morris PL, Robinson RG, Andrzejewski P, et al.: Association of depression with 10-year poststroke mortality. Am J Psychiatry 1993, 150:124–129.PubMedGoogle Scholar
  10. 10.
    Silverstone PH: Depression increases mortality and morbidity in acute life-threatening medical illness. J Psychosom Res 1990, 34:651–657.PubMedCrossRefGoogle Scholar
  11. 11.
    Koenig HG, George LK, Larson DB, et al.: Depressive symptoms and nine-year survival of 1,001 male veterans hospitalized with medical illness. Am J Geriatr Psychiatry 1999, 7:124–131.PubMedGoogle Scholar
  12. 12.
    Covinsky KE, Kahana E, Chin MH, et al.: Depressive symptoms and 3-year mortality in older hospitalized medical patients. Ann Intern Med 1999, 130:563–569.PubMedGoogle Scholar
  13. 13.
    Ganzini L, Smith DM, Fenn DS, Lee LA: Depression and mortality in medically ill older adults. J Am Geriatr Soc 1997, 45:307–312.PubMedGoogle Scholar
  14. 14.
    Wulsin LR, Vaillant GE, Wells VE: A systematic review of the mortality of depression. Psychosom Med 1999, 61:6–17.PubMedGoogle Scholar
  15. 15.
    Saz P, Dewey ME: Depression, depressive symptoms and mortality in persons aged 65 and over living in the community: a systematic review of the literature. Int J Geriatr Psychiatry 2001, 16:622–630. This is a comprehensive and well-conducted systematic review of studies examining the relationship between depression and mortality in the elderly.PubMedCrossRefGoogle Scholar
  16. 16.
    Cole MG, Bellavance F: Depression in elderly medical inpatients: a meta-analysis of outcomes. CMAJ 1997, 157:1055–1060.PubMedGoogle Scholar
  17. 17.
    Penninx BW, Geerlings SW, Deeg DJ, et al.: Minor and major depression and the risk of death in older persons. Arch Gen Psychiatry 1999, 56:889–895. This is one of the most important studies in this area, examining the relationship between depression and mortality, while controlling for the most important confounders.PubMedCrossRefGoogle Scholar
  18. 18.
    Sharma VK, Copeland JR, Dewey ME, et al.: Outcome of the depressed elderly living in the community in Liverpool: a 5-year follow-up. Psychol Med 1998, 28:1329–1337.PubMedCrossRefGoogle Scholar
  19. 19.
    Schoevers RA, Geerlings MI, Beekman AT, et al.: Association of depression and gender with mortality in old age. Results from the Amsterdam Study of the Elderly (AMSTEL). Br J Psychiatry 2000, 177:336–342.PubMedCrossRefGoogle Scholar
  20. 20.
    Zheng D, Macera CA, Croft JB, et al.: Major depression and all-cause mortality among white adults in the United States. Ann Epidemiology 1997, 7:213–218.CrossRefGoogle Scholar
  21. 21.
    Murphy JM, Monson RR, Olivier DC, et al.: Affective disorders and mortality. A general population study. Arch Gen Psychiatry 1987, 44:473–480.PubMedGoogle Scholar
  22. 22.
    Mokdad AH, Marks JS, Stroup DF, Gerberding JL: Actual causes of death in the United States. JAMA 2004, 291:1238–1245.PubMedCrossRefGoogle Scholar
  23. 23.
    Guze SB, Robins E: Suicide and primary affective disorders. Br J Psychiatry 1970, 117:437–438.PubMedCrossRefGoogle Scholar
  24. 24.
    Bostwick JM, Pankratz VS: Affective disorders and suicide risk: A reexamination. Am J Psychiatry 2000, 157:1925–1932.PubMedCrossRefGoogle Scholar
  25. 25.
    Eysenck HJ: Personality and the maintenance of the smoking habit. In Smoking Behavior: Motives and Incentives. Edited by Dunn WL. Washington, DC: Winston; 1973.Google Scholar
  26. 26.
    Pomerleau O, Adkins D, Pertschuk M: Predictors of outcome and recidivism in smoking cessation treatment. Addict Behav 1979, 3:65–370.CrossRefGoogle Scholar
  27. 27.
    Hall SM, Muñoz RF, Reus VI, Sees KL: Nicotine, negative affect, and depression. J Consult Clin Psychol 1993, 61:761–767.PubMedCrossRefGoogle Scholar
  28. 28.
    Glassman AH, Helzer JE, Covey LS, et al.: Smoking, smoking cessation, and major depression. JAMA 1990, 264:1546–1549.PubMedCrossRefGoogle Scholar
  29. 29.
    Anda RF, Williamson DF, Escobedo LG, et al.: Depression and the dynamics of smoking; a national perspective. JAMA 1990, 264:1541–1545.PubMedCrossRefGoogle Scholar
  30. 30.
    Breslau N, Kilbey MM, Andreski P: Nicotine dependence and major depression; new evidence from a prospective investigation. Arch Gen Psychiatry 1993, 50:31–35.PubMedGoogle Scholar
  31. 31.
    Brown RA, Lewinsohn PM, Seeley JR, Wagner EF: Cigarette smoking, major depression, and other psychiatric disorders among adolescents. J Am Child Adolesc Psychiatry 1996, 35:1602–1610.CrossRefGoogle Scholar
  32. 32.
    Covey LS, Glassman AH, Stetner F: Major depression following smoking cessation. Am J Psychiatry 1997, 154:263–265.PubMedGoogle Scholar
  33. 33.
    Dierker LC, Avenevoli S, Stolar M, Merikangas KR: Smoking and depression: An examination of mechanisms of comorbidity. Am J Psychiatry 2002, 159:947–953. This is an excellent review of studies examining the relationship between depression and smoking.PubMedCrossRefGoogle Scholar
  34. 34.
    Holahan CJ, Moos RH, Holahan CK, et al.: Drinking to cope and alcohol use and abuse in unipolar depression: a 10-year model. J Abnorm Psychol 2003, 112:159–165.PubMedCrossRefGoogle Scholar
  35. 35.
    Roeloffs CA, Fink A, Unutzer J, et al.: Problematic substance use, depressive symptoms, and gender in primary care. Psychiatr Serv 2001, 52:1251–1253.PubMedCrossRefGoogle Scholar
  36. 36.
    Aneshensel CS, Huba GJ: Depression, alcohol use, and smoking over one year: a four-wave longitudinal causal model. J Abnorm Psychol 1983, 92:134–150.PubMedCrossRefGoogle Scholar
  37. 37.
    Stephens T: Physical Activity and Mental Health in the United States and Canada: Evidence From Four Population Surveys. Prev Med 1988, 17:35–47.PubMedCrossRefGoogle Scholar
  38. 38.
    Rodgers B, Korten AE, Jorm AF, et al.: Non-linear relationships in associations of depression and anxiety with alcohol use. Psychol Med 2000, 30:421–432.PubMedCrossRefGoogle Scholar
  39. 39.
    Carpenter KM, Hasin DS, Allison DB, Faith MS: Relationships between obesity and DSM-IV major depressive disorder, suicide ideation, and suicide attempts: results from a general population study. Am J Public Health 2000, 90:251–257.PubMedGoogle Scholar
  40. 40.
    Blazer DG, Hybels CF, Pieper CF: The Association of depression and mortality in elderly persons: a case for multiple, independent pathways. J Gerontol Med Sci 2001, 56A:M505-M509.Google Scholar
  41. 41.
    Onyike CU, Crum RM, Lee HB, et al.: Is obesity associated with major depression? Results from the Third National Health and Nutrition Examination Survey. Am J Epidemiol 2003, 158:1139–1147.PubMedCrossRefGoogle Scholar
  42. 42.
    Pokorski RJ: Underwriting psychiatric impairments, with emphasis on depression; part I: psychiatric mortality and common underwriting parameters. J Insurance Med 1994, 26:46–56.Google Scholar
  43. 43.
    Lustman PJ, Anderson RJ, Freedland KE, et al.: Depression and poor glycemic control: a meta-analytic review of the literature. Diabetes Care 2000, 23:934–942.PubMedCrossRefGoogle Scholar
  44. 44.
    Spiegel D, Giese-Davis J: Depression and cancer: mechanisms and disease progression. Biol Psychiatry 2003, 54:269–282.PubMedCrossRefGoogle Scholar
  45. 45.
    Pirl WF, Roth AJ: Diagnosis and treatment of depression in cancer patients. Oncology (Huntingt) 1999, 13:1293–1301.Google Scholar
  46. 46.
    Kiecolt-Glaser J, Glaser R: Depression and immune function; Central pathways to morbidity and mortality. J Psychosom Res 2002, 53:873–876. This is an excellent overview of the relationship between depression and immune function.PubMedCrossRefGoogle Scholar
  47. 47.
    Katon W, Ciechanowski P: Impact of major depression on chronic medical illness. J Psychosom Res 2002, 53:859–863.PubMedCrossRefGoogle Scholar
  48. 48.
    Wells KB, Rogers W, Burnam A, et al.: How the medical comorbidity of depressed patients differs across health care settings: results from the medical outcomes study. Am J Psychiatry 1991, 148:1688–1696.PubMedGoogle Scholar
  49. 49.
    Katon W, Sullivan MD: Depression and chronic medical illness. J Clin Psychiatry 1990, 51(suppl):3–11.PubMedGoogle Scholar
  50. 50.
    Roose SP, Glassman AH, Seidman SN: Relationship between depression and other medical illnesses. JAMA 2001, 286:1687–1690.PubMedCrossRefGoogle Scholar
  51. 51.
    Joynt KE, Whellan DJ, O’Conner CM: Depression and cardiovascular disease: mechanisms of interaction. Biol Psychiatry 2003, 54:248–261.PubMedCrossRefGoogle Scholar
  52. 52.
    Penninx BW, Beekman AT, Honig A, et al.: Depression and cardiac mortality: results from a community-based longitudinal study. Arch Gen Psychiatry 2001, 58:221–227.PubMedCrossRefGoogle Scholar
  53. 53.
    Ford DE, Mead LA, Chang P, et al.: Depression is a risk factor for coronary artery disease in men: the precursors study. Arch Intern Med 1998, 158:1422–1426.PubMedCrossRefGoogle Scholar
  54. 54.
    Eaton WW, Armenian H, Gallo J, et al.: Depression and risk for onset of type II diabetes. A prospective population-based study. Diabetes Care 1996, 19:1097–1102.PubMedCrossRefGoogle Scholar
  55. 55.
    Kawakami N, Takatsuka N, Shimizu H, Ishibashi H: Depressive symptoms and occurrence of type 2 diabetes among Japanese men. Diabetes Care 1999, 22:1071–1076.PubMedCrossRefGoogle Scholar
  56. 56.
    Carney R, Freedland K, Miller G, Jaffe AS: Depression as a risk factor for cardiac mortality and morbidity: A review of potential mechanisms. J Psychosom Res 2002, 53:897–902. This is a comprehensive review of the mechanisms explaining the relationship between depression and mortality, with a focus on biological mechanisms.PubMedCrossRefGoogle Scholar
  57. 57.
    Holsboer F: The corticosteroid receptor hypothesis of depression. Neuropsychopharmacology 2000, 23:477–501.PubMedCrossRefGoogle Scholar
  58. 58.
    Pariante CM: Depression, stress and the adrenal axis. J Neuroendocrinol 2003, 15:811–812.PubMedCrossRefGoogle Scholar
  59. 59.
    Musselman DL, Nemeroff CB: Depression and endocrine disorders: focus on the thyroid and adrenal system. Br J Psychiatry Suppl 1996, 30:123–128.PubMedGoogle Scholar
  60. 60.
    Bjorntorp P, Rosmond R: Visceral obesity and diabetes. Drugs 1999, 58(suppl 1):13–18.PubMedCrossRefGoogle Scholar
  61. 61.
    Kaplan NM: The deadly quartet. Upper-body obesity, glucose intolerance, hypertriglyceridemia, and hypertension. Arch Intern Med 1989, 149:1514–1520.PubMedCrossRefGoogle Scholar
  62. 62.
    Michelson D, Stratakis C, Hill L, et al.: Bone mineral density in women with depression. N Engl J Med 1996, 335:1176–1181.PubMedCrossRefGoogle Scholar
  63. 63.
    Muller M, Holsboer F, Keck ME: Genetic modification of corticosteroid receptor signalling: novel insights into pathophysiology and treatment strategies of human affective disorders. Neuropeptides 2002, 36:117–131.PubMedCrossRefGoogle Scholar
  64. 64.
    Krieg JC, Lauer CJ, Schreiber W, et al.: Neuroendocrine, polysomnographic and psychometric observations in healthy subjects at high familial risk for affective disorders: the current state of the ’Munich vulnerability study‘. J Affect Disord 2001, 62:33–37.PubMedCrossRefGoogle Scholar
  65. 65.
    Maes M, Meltzer HY, Bosmans E, et al.: Increased plasma concentrations of interleukin-6, soluble interleukin-6, soluble interleukin-2 and transferrin receptor in major depression. J Affect Disord 1995, 34:301–309.PubMedCrossRefGoogle Scholar
  66. 66.
    Penninx BW, Kritchevsky SB, Yaffe K, et al.: Inflammatory markers and depressed mood in older persons: results from the Health, Aging and Body Composition study. Biol Psychiatry 2003, 54:566–572.PubMedCrossRefGoogle Scholar
  67. 67.
    Sapolsky R, Rivier C, Yamamoto G, et al.: Interleukin-1 stimulates the secretion of hypothalamic corticotropin-releasing factor. Science 1987, 238:522–524.PubMedCrossRefGoogle Scholar
  68. 68.
    Ridker PM, Buring JE, Shih J, et al.: Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women. Circulation 1998, 98:731–733.PubMedGoogle Scholar
  69. 69.
    Ridker PM, Rifai N, Stampfer MJ, Hennekens CH: Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. Circulation 2000, 101:1767–1772.PubMedGoogle Scholar
  70. 70.
    Shah PK: Circulating markers of inflammation for vascular risk prediction: are they ready for prime time. Circulation 2000, 101:1758–1759.PubMedGoogle Scholar
  71. 71.
    Cesari M, Penninx BW, Newman A, et al.: Inflammatory markers and onset of cardiovascular events: results from the Health ABC study. Circulation 2003, 108:2317–2322.PubMedCrossRefGoogle Scholar
  72. 72.
    Reichenberg A, Yirmiya R, Schuld A, et al.: Cytokine-associated emotional and cognitive disturbances in humans. Arch Gen Psychiatry 2001, 58:445–452.PubMedCrossRefGoogle Scholar
  73. 73.
    Roy A, Pickar D, De Jong J, et al.: Norepinephrine and its metabolites in cerebrospinal fluid, plasma, and urine. Relationship to hypothalamic-pituitary-adrenal axis function in depression. ArchGen Psychiatry 1988, 45:849–857.Google Scholar
  74. 74.
    Carney RM, Saunders RD, Freedland KE, et al.: Association of depression with reduced heart rate variability in coronary artery disease. Am J Cardiol 1995, 76:562–564.PubMedCrossRefGoogle Scholar
  75. 75.
    Musselman DL, Evans DL, Nemeroff CB: The relationship of depression to cardiovascular disease: epidemiology, biology, and treatment. Arch Gen Psychiatry 1998, 55:580–592. Comprehensive, well written and illustrated review of biological mechanisms linking depression and cardiovascular disorders.PubMedCrossRefGoogle Scholar
  76. 76.
    Alexopoulos GS, Buckwalter K, Olin J, et al.: Comorbidity of late life depression: an opportunity for research on mechanisms and treatment. Biol Psychiatry 2002, 52:543–558.PubMedCrossRefGoogle Scholar
  77. 77.
    Thomas AJ, Kalaria RN, O’Brien JT: Depression and vascular disease: what is the relationship? J Affect Disord 2004, 79:81–95.PubMedCrossRefGoogle Scholar
  78. 78.
    Catz SL, Kelly JA, Bogart LM, et al.: Patterns, correlates, and barriers to medication adherence among persons prescribed new treatments for HIV disease. Health Psychol 2000, 19:124–133.PubMedCrossRefGoogle Scholar
  79. 79.
    Richardson JL, Marks G, Johnson CA, et al.: Path model of multidimensional compliance with cancer therapy. Health Psychol 1987, 6:183–207.PubMedCrossRefGoogle Scholar
  80. 80.
    Carney R: Major depression and medication adherence in elderly patients with coronary artery disease. Health Psychology 1995, 14:88–90.PubMedCrossRefGoogle Scholar
  81. 81.
    DiMatteo MR, Lepper HS, Croghan TW: Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence. Arch Intern Med 2000, 160:2101–2107.PubMedCrossRefGoogle Scholar
  82. 82.
    Wing RR, Phelan S, Tate D: The role of adherence in mediating the relationship between depression and health outcomes. J Psychosom Res 2002, 53:877–881.PubMedCrossRefGoogle Scholar
  83. 83.
    Althaus D, Hegerl U: The evaluation of suicide prevention activities: state of the art. World J Biol Psychiatry 2003, 4:156–165.PubMedCrossRefGoogle Scholar
  84. 84.
    Tondo L, Hennen J, Baldessarini RJ: Lower suicide risk with long-term lithium treatment in major affective illness: a meta-analysis. Acta Psychiatr Scand 2001, 104:163–172.PubMedCrossRefGoogle Scholar
  85. 85.
    Aseltine RH Jr, DeMartino R: An outcome evaluation of the SOS Suicide Prevention Program. Am J Public Health 2004, 94:446–451.PubMedCrossRefGoogle Scholar
  86. 86.
    Motto JA, Bostrom AG: A randomized controlled trial of postcrisis suicide prevention. Psychiatr Serv 2001, 52:828–833.PubMedCrossRefGoogle Scholar
  87. 87.
    Bruce M, Ten Have T, Katz I, et al.: Reducing suicidal ideation and depressive symptoms in depressed older primary care patients. A randomized controlled trial. JAMA 2004, 291:1081–1091.PubMedCrossRefGoogle Scholar
  88. 88.
    Hall SM, Reus VI, Munoz RF, et al.: Nortriptyline and cognitive-behavioral therapy in the treatment of cigarette smoking. Arch Gen Psychiatry 1998, 55:683–690.PubMedCrossRefGoogle Scholar
  89. 89.
    Hall SM, Munoz RF, Reus VI, et al.: Mood management and nicotine gum in smoking treatment: a therapeutic contact and placebo-controlled study. J Consult Clin Psychol 1996, 64:1003–1009.PubMedCrossRefGoogle Scholar
  90. 90.
    Hall SM, Munoz RF, Reus VI: Cognitive-behavioral intervention increases abstinence rates for depressive-history smokers. J Consult Clin Psychol 1994, 62:141–146.PubMedCrossRefGoogle Scholar
  91. 91.
    Patten CA, Martin JE, Myers MG, et al.: Effectiveness of cognitive-behavioral therapy for smokers with histories of alcohol dependence and depression. J Stud Alcohol 1998, 59:327–335.PubMedGoogle Scholar
  92. 92.
    Peterson AM, Takiya L, Finley R: Meta-analysis of trials of interventions to improve medication adherence. Am J Health Syst Pharm 2003, 60:657–665.PubMedGoogle Scholar
  93. 93.
    Glassman AH, Roose SP, Bigger JT: The safety of tricyclic antidepressants in cardiac patients. Risk-benefit reconsidered. JAMA 1993, 269:2673–2675.PubMedCrossRefGoogle Scholar
  94. 94.
    Roose SP, Glassman AH: Antidepressant choice in the patient with cardiac disease: lessons from the Cardiac Arrhythmia Suppression Trial (CAST) studies. J Clin Psychiatry 1994, 55(suppl A):83–87.PubMedGoogle Scholar
  95. 95.
    Avery D, Winokur G: Mortality in depressed patients treated with electroconvulsive therapy and antidepressants. Arch Gen Psychiatry 1976, 33:1029–1037.PubMedGoogle Scholar
  96. 96.
    Craig TJ, Lin SP: Mortality among psychiatric inpatients. Ageadjusted comparison of populations before and after psychotropic drug era. Arch Gen Psychiatry 1981, 38:935–938.PubMedGoogle Scholar
  97. 97.
    Sauer WH, Berlin JA, Kimmel SE: Selective serotonin reuptake inhibitors and myocardial infarction. Circulation 2001, 104:1894–1898.PubMedGoogle Scholar
  98. 98.
    Jorge RE, Robinson RG, Arndt S, Starkstein S: Mortality and poststroke depression: a placebo-controlled trial of antidepressants. Am J Psychiatry 2003, 160:1823–1829.PubMedCrossRefGoogle Scholar
  99. 99.
    Musselman DL, Marzec UM, Manatunga A, et al.: Platelet reactivity in depressed patients treated with paroxetine: Preliminary findings. Arch Gen Psychiatry 2000, 57:875–882.PubMedCrossRefGoogle Scholar
  100. 100.
    Budziszewska B, Jaworska-Feil L, Tetich M, et al.: Regulation of the human corticotropin-releasing-hormone gene promoter activity by antidepressant drugs in Neuro-2A and AtT-20 cells. Neuropsychopharmacology 2004, 29:785–794.PubMedCrossRefGoogle Scholar
  101. 101.
    Nemeroff CB, Owens MJ: Pharmacologic differences among the SSRIs: Focus on monoamine transporters and the HPA axis. CNS Spectr 2004, 9(suppl 4):23–31.PubMedGoogle Scholar
  102. 102.
    Glassman AH, O’Connor CM, Califf RM, et al.: Sertraline treatment of major depression in patients with acute MI or unstable angina. JAMA 2002, 288:701–709.PubMedCrossRefGoogle Scholar
  103. 103.
    Berkman LF, Blumenthal J, Burg M, et al.: Enhancing Recovery in Coronary Heart Disease Patients Investigators (ENRICHD). Effects of treating depression and low perceived social support on clinical events after myocardial infarction: the Enhancing Recovery in Coronary Heart Disease Patients (ENRICHD) Randomized Trial. JAMA 2003, 289:3106–3116.PubMedCrossRefGoogle Scholar
  104. 104.
    Linden W, Stossel C, Maurice J: Psychosocial interventions for patients with coronary artery disease: a meta-analysis. Arch Intern Med 1996, 156:745–752.PubMedCrossRefGoogle Scholar

Copyright information

© Current Science Inc 2004

Authors and Affiliations

  • Pim Cuijpers
    • 1
  • Robert A. Schoevers
  1. 1.Department of Clinical PsychologyVrije Universiteit, AmsterdamBT AmsterdamThe Netherlands

Personalised recommendations